DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: allopurinol

Summary for Generic Name: allopurinol

Tradenames:5
Patents:0
Applicants:18
NDAs:29
Drug Master File Entries: see list21
Suppliers: see list9
Therapeutic Class:Antigout Agents

Pharmacology for Ingredient: allopurinol

Clinical Trials for: allopurinol

A Pilot Study for Pharmacokinetic/Pharmacodynamic (PK/PD) Parameter of Allopurinol and Its Metabolite-oxypurinol After Once-daily Allopurinol in Chronic Kidney Disease Patient
Status: Recruiting Condition: Chronic Kidney Disease

A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL
Status: Recruiting Condition: Acute Lymphoblastic Leukemia (ALL)

Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study
Status: Enrolling by invitation Condition: End Stage Renal Disease; Left Ventricular Hypertrophy

Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode
Status: Completed Condition: Mania

Allopurinol Combination Study
Status: Active, not recruiting Condition: Gout

Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia
Status: Completed Condition: Gout; Hyperuricemia

Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia
Status: Completed Condition: Schizophrenia; Schizoaffective Disorder

The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
Status: Terminated Condition: Blood Pressure; Gout

Allopurinol in Acute Coronary Syndrome
Status: Recruiting Condition: Chronic Stable Angina

Allopurinol Outcome Study
Status: Completed Condition: Gout

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare
ALLOPURINOL
allopurinol
TABLET;ORAL203154May 6, 2013RXNo<disabled><disabled>
Apotex Inc
ALLOPURINOL
allopurinol
TABLET;ORAL077353Sep 8, 2005RXNo<disabled><disabled>
Caraco
ALLOPURINOL
allopurinol
TABLET;ORAL078390Aug 30, 2007RXNo<disabled><disabled>
Ipca Labs Ltd
ALLOPURINOL
allopurinol
TABLET;ORAL090637Mar 16, 2011RXNo<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc